Boise, Idaho – November 04, 2026 -- NNB Nutrition spent three years and $2.5 million developing the patented stevia Reb M9 now anchoring its SweetVantage sweetener blend, one of several launches the company showed at SupplySide Global 2026 in Las Vegas on October 28-30.
At Booth #5952 at Mandalay Bay, the company met formulators, brand owners and media across four areas: natural sweeteners, dipeptide performance ingredients, ultra-pure creatine and fermentation-derived actives. Dustin Elliott, Chief Brand Officer of NNB Nutrition USA, said more brands are entering functional food and want "low-dose, high-potency" ingredients alongside clean labels.
SweetVantage adds Reb M9 and brazzein to target sucralose-dependent formulas
SweetVantage is a fermented steviol glycoside blend. NNB says it targets the front, middle and back of the palate, with lower astringency than other natural sweeteners and a lower cost than stevia Reb M. In a research panel, Reb M9 performed closest to sugar against other natural sweeteners. The blend can be labeled simply as "Steviol Glycosides."
SweetVantage+ adds brazzein, a fermented, non-caloric sweet protein. The patent-pending combination is aimed at bitterness masking in EAAs, herbal extracts, protein, greens and complex sports formulas, which have traditionally relied on sucralose or bitter blockers. NNB can adjust the brazzein ratio to each formula.
VasoRush raised plasma cGMP 85% in NNB's in-house pre-clinical testing
VasoRush is a 2:1 di-citrulline and di-arginine peptide complex built around vasodilation efficiency through cGMP. NNB says both dipeptides qualify as legal dietary ingredients that need no new regulatory registrations. A legal assessment in the EU concluded they should not be classified as novel foods.
At a human-equivalent dose of 2.7 g/day, VasoRush increased plasma cGMP by 85% and kept nitric oxide elevated for up to six hours. It also increased running time to exhaustion by 15.9% versus exercise control. NNB reports it outperformed 8 g doses of citrulline, citrulline malate and arginine.
DL 185, a patented dileucine available exclusively from NNB, completes the dipeptide line. Matching a 2 g serving from food would take 159 g of whey protein concentrate or 219 g of pea protein. In human research cited by NNB (Paulussen et al., 2021), 2 g delivered 86% more leucine to muscles within 30 minutes and a 60% greater increase in muscle protein synthesis than the same amount of leucine.
Puerest Creatine is priced at nearly half the cost of other high-purity creatines
Puerest Creatine uses a proprietary synthesis method that avoids reaction pathways that create hazardous byproducts. NNB says it has the industry's lowest levels of DCD, DHT and creatinine, verified by third-party testing, and less than 1.0 ppm of each heavy metal. Every lot is tested with a validated Eurofins method that detects previously undetectable levels of DCD and DHT, and retain samples are held.
The product is vegan, allergen-free, non-GMO and Informed Choice certified. It recently won the Greater Bay Area Selected Healthy Ingredients Gold Award at Hi & Fi Asia-China.
Fermented MitoPrime and SalidroPure target supply limits on mushroom and Rhodiola sources
MitoPrime is a pure L-isomer of L-ergothioneine made through patented fermentation. Reaching an active dose from fresh king oyster mushroom would take 20 g. NNB says fermentation requires less biomass than extraction, uses no harsh solvents and carries a lower carbon footprint. The ingredient is self-affirmed GRAS. In human research cited by NNB (Okumura et al., 2025), a 20 mg dose produced a 2.3x increase in plasma ergothioneine and improvements in subjective sleep quality.
SalidroPure is fermented, non-GMO salidroside, a key active compound in Rhodiola rosea. Rhodiola is now subject to international trade restrictions under CITES, which has made high-concentration extracts harder to source. A 20-30 mg dose of SalidroPure provides the salidroside found in roughly 2,000 mg of Rhodiola rosea, small enough for gummies, smaller capsules and dissolving strips. It is self-affirmed GRAS up to 87.2 mg.
OnSwitch concept drink carries NNB actives into ready-to-consume formats
NNB also showed OnSwitch, a ready-to-drink concept beverage built to go beyond caffeine. It combines MitoPrime and SalidroPure to support energy, focus and resilience.
NNB provides ingredient information as a resource for claim development, and brands remain responsible for substantiating their finished-product claims.